12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant price movements during Monday's pre-market session, with Timber Pharmaceuticals, Evaxion Biotech, and BiondVax Pharmaceuticals among the gainers, while Bellerophon Therapeutics, Mallinckrodt, and Cibus were among the losers.
June 05, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bellerophon Therapeutics' stock declined by 79.3% to $1.46 during Monday's pre-market session, with a market cap of $15.2 million.
Bellerophon Therapeutics' significant share price decline of 79.3% during the pre-market session is likely to have a negative short-term impact on the stock. The sharp decrease indicates a lack of investor confidence and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Cibus' shares fell 19.64% to $19.61, with a market cap of $19.5 million.
Cibus' share price decline of 19.64% during the pre-market session is likely to have a negative short-term impact on the stock. The significant decrease indicates a lack of investor confidence and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Mallinckrodt's shares fell 23.08% to $1.88, with a market value of $24.8 million.
Mallinckrodt's share price decline of 23.08% during the pre-market session is likely to have a negative short-term impact on the stock. The significant decrease indicates a lack of investor confidence and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
BiondVax Pharmaceuticals' stock moved upwards by 27.64% to $2.17, with a market cap of $7.1 million.
BiondVax Pharmaceuticals' share price increase of 27.64% during the pre-market session is likely to have a positive short-term impact on the stock. The significant increase indicates strong investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Evaxion Biotech's shares moved upwards by 43.24% to $2.12, with a market value of $56.0 million. Q1 earnings were released 3 days ago.
Evaxion Biotech's share price increase of 43.24% during the pre-market session is likely to have a positive short-term impact on the stock. The recent release of Q1 earnings may have contributed to the increased investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Timber Pharmaceuticals' shares increased by 87.9% to $2.8 during Monday's pre-market session, with a market cap of $8.5 million.
Timber Pharmaceuticals' significant share price increase during the pre-market session is likely to have a positive short-term impact on the stock. The 87.9% increase indicates strong investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100